Merck is about to perform post-marketing safety study of HPBCD-containing PREVYMIS™ injection
Merck Sharp and Dohme LLC. has received initial U.S. Approval: 2017 PREVYMIS™ (letermovir) injection, for intravenous use. In the first
A forum for researchers, students and applicants in the field of cyclodextrin technology
Merck Sharp and Dohme LLC. has received initial U.S. Approval: 2017 PREVYMIS™ (letermovir) injection, for intravenous use. In the first
Drug Development & Delivery published an interesting review on sulfobutyl ether beta-cyclodextrin (Captisol) in its October issue (2023). In addition
The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal
As repurposing ivermectin against Covid-19 is still in the focus of debates and as this drug can be formulated with
Niemann-Pick disease type C (NPC) is a lysosomal storage disorder with disrupted intracellular cholesterol trafficking. HP-β-CD is a cholesterol solubilizer
Italian researchers developed an oral spray (Endovir Stop) containing alpha-cyclodextrin (0.2%) and hydroxytyrosol (3.8%) for the improvement of the defenses